Navigation Links
QED International Associates Announces Changes to the HealthShares(TM) Composite, and the HealthShares(TM) Diagnostics Indexes
Date:11/6/2007

NEW YORK, Nov. 6 /PRNewswire/ -- QED International Associates Inc., administrator for the HealthShares(TM) Exchange-Traded Funds, a series of 20 underlying fund portfolios, today announced that effective at the opening of trading on Thursday November 8, 2007 Given Imaging, Ltd. (Nasdaq: GIVN) will replace Dade Behring Holdings, Inc. (Nasdaq: DADE), in the HealthShares(TM) Diagnostics Index, and Inverness Medical Innovations (Amex: IMA) will replace DADE in the HealthShares(TM) Composite Index. Dade Behring is being acquired by Siemens, Inc.

Companies included in the HealthShares(TM) Diagnostics Index engage in identification of the existence and extent of a disease, the visual localization of a disease by way of imaging, the selection of therapeutic agents appropriate for the disease wherever possible and the monitoring of disease progression/therapeutic efficacy.

About HealthShares(TM)

XShares Advisors LLC, a financial services company based in New York, is the creator of the HealthShares(TM) family of Exchange Traded Funds (ETFs). HealthShares(TM) ETFs are organized into therapeutic 'Verticals' and represent specific areas of the healthcare, life science and biotechnology industries. Each Vertical addresses a distinc
'/>"/>

SOURCE QED International Associates Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
3. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
4. LCA Hails International Investigators Studying Lung Cancer
5. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
6. PRA International Adds Dr. Susan Stansfield as Executive Vice President
7. Medical Services International Maintains Pace in Second Quarter
8. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
9. International Gateway Insurance Brokers Partners With MEDILINQ
10. Tulane University to receive $14M for international HIV/AIDS program
11. International Database Seeks to Boost Treatment of Altitude Sickness
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3The Army Awards Follow-On Contract for Autonomous Airway Management to Energid Technologies 2AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 2AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 3Simulating medical situations helps students learn retain basic science concepts 51568 1Simulating medical situations helps students learn retain basic science concepts 51568 2July August 2009 Annals of Family Medicine tip sheet 51565 1July August 2009 Annals of Family Medicine tip sheet 51565 2July August 2009 Annals of Family Medicine tip sheet 51565 3July August 2009 Annals of Family Medicine tip sheet 51565 4July August 2009 Annals of Family Medicine tip sheet 51565 5July August 2009 Annals of Family Medicine tip sheet 51565 6July August 2009 Annals of Family Medicine tip sheet 51565 7New drugs faster from natural compounds 3A A UC San Diego breakthrough 13003 1New drugs faster from natural compounds 3A A UC San Diego breakthrough 13003 2New drugs faster from natural compounds 3A A UC San Diego breakthrough 13003 3New drugs faster from natural compounds 3A A UC San Diego breakthrough 13003 4